Enzymatic Modifications of Protein S: Implications for Diagnostics and Anticoagulant Function
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Enzymatic modifications of protein S: cause and impact on diagnostics, plasma processing, and anticoagulant properties
This review discusses how enzymatic modifications, such as phosphorylation and proteolysis, can alter the anticoagulant functions of protein S, which is essential for downregulating coagulation.
These changes can impact diagnostic procedures, plasma product quality, and overall thrombosis risk, highlighting new opportunities for improved therapies and clinical diagnostics.
Read this paper.
Authors: Herm Jan Brinkman”
Article: Enzymatic modifications of protein S: cause and impact on diagnostics, plasma processing, and anticoagulant properties
Authors: Herm Jan Brinkman
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice